Endocrine management of breast cancer and advanced breast cancer

Bookmark and Share
Published: 2 Apr 2012
Views: 3713
Rating:
Save
Prof Stephen Johnston - Royal Marsden Hospital, London, UK

Prof Stephen Johnston speaks on treatment of breast cancer and advanced breast cancer with aromotase inhibitors, tamoxifen, fulvestrant and previous trials using endocrine therapy at EBCC 8.

 

Prof Johnston highlights the need for selecting patients in these trials that will benefit from the trials as many only extend progression free survival by three to four months.